Current:Home > MySimone Biles leads at US Olympic trials, but shaky beam routine gets her fired up -StockSource
Simone Biles leads at US Olympic trials, but shaky beam routine gets her fired up
View
Date:2025-04-24 17:56:39
Editor’s note: Follow the latest U.S. Olympic gymnastics trials results.
MINNEAPOLIS — The expletive wasn't audible amid the cheering at Target Center, nor heard on NBC's television coverage. But it was clearly visible on the jumbotron as Simone Biles walked away from the balance beam Friday night, evidence of the frustration she felt after a shaky routine at the U.S. Olympic gymnastics trials.
That score, and a bit of rotational happenstance, briefly left the world's greatest gymnast in second place.
"She was very, very pissed," her coach Laurent Landi said.
None of it lasted very long, of course. Biles proceeded to drop a masterful floor routine and another one of her iconic Yurchenko double pikes on vault, drawing a standing ovation from the crowd. By the end of the night, she was 2.5 points clear of the rest of the field and roughly 48 hours away from her third trip to the Summer Olympic Games.
Get Olympics updates in your texts! Join USA TODAY Sports' WhatsApp Channel
That Biles is atop the leaderboard after the first night of trials, with a score of 58.900, is hardly a surprise given her recent performances and general dominance. The interesting part was that, unlike some of her recent meets, she had to block out some metaphorical noise Friday night to get there.
Biles started off on uneven bars, which has generally been her least-favorite event − even though she registered the second-highest score of the night on it Friday. Then she moved to balance beam, where she started with an uncharacteristic wobble and ended with a hop on the dismount, resulting in a score of 13.650 that was more than a full point lower than her two beam routines at nationals.
"I'm so upset about beam," Biles told NBC in a brief interview posted on Instagram. "I'm really disappointed in myself because that's not how I train. And so going forward, I'm going to try to compete how I train on that event. Because I know I'm good at it. I know I can do better. So that's what I'm going to work on."
Biles, 27, was also likely rattled to some extent by the injuries earlier in the night involving two of her potential Team USA teammates. She checked in on Shilese Jones, the reigning world bronze medalist, after Jones injured her knee on a vault in warmups, which prompted her to withdraw from three of her four events on the night. And she couldn't have avoided seeing Kayla DiCello being helped out of the arena after sustaining her own injury on vault.
"She needs to really calm herself down. She needs to rely on her practice," Landi said. "Podium training, you should have seen, she hits everything perfectly normal. And because of this, there is anxiety. Am I the next one to get hurt? What's going to happen to me? You can't control this. So control the controllable."
And for Biles, those controllables have often been her best two events: Floor exercise and vault.
On floor, Biles didn't eclipse the 15-point mark like she did at nationals, but she turned in a performance that Landi called "almost perfect." The highlight was a particularly soaring and emphatic version of the eponymous Biles II on her first tumbling pass − a triple-double that ranks among the most impressive skills in her repertoire. "Two flips, three twists − you can't even count it fast enough. Incredible," Samantha Peszek said on NBC. A slight step out of bounds was one of the routine's few blemishes.
And that set the stage for vault, where Biles' famed Yurchenko double pike drew a 9.75 execution score from the judges (out of a possible 10) and brought the Target Center crowd to its feet. Biles smiled as she walked back to the start of the runway, then waved as the standing ovation continued.
"So at the end of four events, and (a) very stressful (night), it was a great recovery," Landi said.
Contact Tom Schad at tschad@usatoday.com or on social media @Tom_Schad.
veryGood! (3747)
Related
- From family road trips to travel woes: Americans are navigating skyrocketing holiday costs
- Tribeca Festival to debut 5 movies using AI after 2023 actors and writers strikes
- Can you hear me now? Verizon network outage in Midwest, West is now resolved, company says
- NYC couple finds safe containing almost $100,000 while magnet fishing in muddy Queens pond
- Sonya Massey's father decries possible release of former deputy charged with her death
- Nebraska woman declared dead at nursing home discovered breathing at funeral home 2 hours later
- Big GOP funders sending millions into Missouri’s attorney general primary
- Survey finds fifth of Germans would prefer more White players on their national soccer team
- Buckingham Palace staff under investigation for 'bar brawl'
- Why Brooke Shields Is Saying F--k You to Aging Gracefully
Ranking
- Average rate on 30
- Man who escaped Oregon hospital while shackled and had to be rescued from muddy pond sentenced
- Prisoner dies 12 days after Pennsylvania judge granted compassionate release for health reasons
- Geno Auriemma signs 5-year extension to continue run as UConn women's basketball coach
- McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales
- Tech news site Gizmodo sold for third time in 8 years as European publisher Keleops looks to expand
- Review: The Force is not with new 'Star Wars' series 'The Acolyte'
- Gunman captured after shootout outside US Embassy in Lebanon
Recommendation
Trump wants to turn the clock on daylight saving time
The Book Report: Washington Post critic Ron Charles (June 2)
No sets? Few props? No problem, says Bebe Neuwirth on ‘deconstructed’ ‘Cabaret’ revival
Maine company plans to launch small satellites starting in 2025
How to watch new prequel series 'Dexter: Original Sin': Premiere date, cast, streaming
New York considers regulating what children see in social media feeds
Man sentenced to 40 years to life for killing mother after argument over video game volume
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication